White matter structural differences in young children with type 1 diabetes: a diffusion tensor imaging study

Diabetes Care. 2012 Nov;35(11):2167-73. doi: 10.2337/dc12-0017. Epub 2012 Sep 10.

Abstract

Objective: To detect clinical correlates of cognitive abilities and white matter (WM) microstructural changes using diffusion tensor imaging (DTI) in young children with type 1 diabetes.

Research design and methods: Children, ages 3 to <10 years, with type 1 diabetes (n = 22) and age- and sex-matched healthy control subjects (n = 14) completed neurocognitive testing and DTI scans.

Results: Compared with healthy controls, children with type 1 diabetes had lower axial diffusivity (AD) values (P = 0.046) in the temporal and parietal lobe regions. There were no significant differences between groups in fractional anisotropy and radial diffusivity (RD). Within the diabetes group, there was a significant, positive correlation between time-weighted HbA(1c) and RD (P = 0.028). A higher, time-weighted HbA(1c) value was significantly correlated with lower overall intellectual functioning measured by the full-scale intelligence quotient (P = 0.03).

Conclusions: Children with type 1 diabetes had significantly different WM structure (as measured by AD) when compared with controls. In addition, WM structural differences (as measured by RD) were significantly correlated with their HbA(1c) values. Additional studies are needed to determine if WM microstructural differences in young children with type 1 diabetes predict future neurocognitive outcome.

Trial registration: ClinicalTrials.gov NCT00449891.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / metabolism
  • Brain / pathology
  • Child
  • Child, Preschool
  • Diabetes Mellitus, Type 1 / metabolism
  • Diabetes Mellitus, Type 1 / pathology*
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Diffusion Magnetic Resonance Imaging
  • Diffusion Tensor Imaging / methods*
  • Female
  • Glycated Hemoglobin / metabolism
  • Humans
  • Male
  • Parietal Lobe / metabolism
  • Parietal Lobe / pathology

Substances

  • Glycated Hemoglobin A

Associated data

  • ClinicalTrials.gov/NCT00449891